Ryvu Therapeutics SA (RVU) — Cash Flow-to-Debt Ratio
Ryvu Therapeutics SA (RVU) has a Cash Flow-to-Debt Ratio of -0.14x as of March 2026, meaning its operating cash flow of zł-22.84 Million could theoretically repay 0% of its total liabilities (zł159.63 Million) in one year. See Ryvu Therapeutics SA (RVU) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ryvu Therapeutics SA Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Ryvu Therapeutics SA across 16 annual periods. For the full cash flow conversion analysis, see RVU cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Ryvu Therapeutics SA (2010–2025)
Year-by-year debt coverage analysis for Ryvu Therapeutics SA. Check Ryvu Therapeutics SA (RVU) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.72x | zł-110.28 Million | zł153.69 Million | ▼ -30.2% |
| 2024 | -0.55x | zł-129.48 Million | zł234.89 Million | ▲ +6.4% |
| 2023 | -0.59x | zł-84.55 Million | zł143.61 Million | ▼ -463.4% |
| 2022 | 0.16x | zł21.32 Million | zł131.59 Million | ▲ +116.6% |
| 2021 | -0.97x | zł-57.87 Million | zł59.39 Million | ▼ -558.8% |
| 2020 | -0.15x | zł-10.64 Million | zł71.92 Million | ▲ +46.3% |
| 2019 | -0.28x | zł-17.40 Million | zł63.13 Million | ▲ +54.0% |
| 2018 | -0.60x | zł-36.42 Million | zł60.84 Million | ▼ -315.7% |
| 2017 | 0.28x | zł10.98 Million | zł39.58 Million | ▲ +247.6% |
| 2016 | -0.19x | zł-6.28 Million | zł33.41 Million | ▲ +79.0% |
| 2015 | -0.89x | zł-16.43 Million | zł18.36 Million | ▼ -220.3% |
| 2014 | -0.28x | zł-4.90 Million | zł17.55 Million | ▲ +99.4% |
| 2013 | -46.80x | zł-694.94 Million | zł14.85 Million | ▼ -5060.4% |
| 2012 | -0.91x | zł-8.90 Million | zł9.82 Million | ▲ +8.4% |
| 2011 | -0.99x | zł-5.98 Million | zł6.04 Million | ▼ -134.1% |
| 2010 | -0.42x | zł-3.71 Million | zł8.77 Million | — |